These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15210573)

  • 1. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.
    Douglas SA; Naselsky D; Ao Z; Disa J; Herold CL; Lynch F; Aiyar NV
    Br J Pharmacol; 2004 Jul; 142(6):921-32. PubMed ID: 15210573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
    Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
    Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.
    Douglas SA; Behm DJ; Aiyar NV; Naselsky D; Disa J; Brooks DP; Ohlstein EH; Gleason JG; Sarau HM; Foley JJ; Buckley PT; Schmidt DB; Wixted WE; Widdowson K; Riley G; Jin J; Gallagher TF; Schmidt SJ; Ridgers L; Christmann LT; Keenan RM; Knight SD; Dhanak D
    Br J Pharmacol; 2005 Jul; 145(5):620-35. PubMed ID: 15852036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
    Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
    Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
    Behm DJ; Ao Z; Camarda V; Aiyar NV; Johns DG; Douglas SA
    Eur J Pharmacol; 2005 Jun; 516(3):276-81. PubMed ID: 15975570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes.
    Castel H; Diallo M; Chatenet D; Leprince J; Desrues L; Schouft MT; Fontaine M; Dubessy C; Lihrmann I; Scalbert E; Malagon M; Vaudry H; Tonon MC; Gandolfo P
    J Neurochem; 2006 Oct; 99(2):582-95. PubMed ID: 16942596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and pharmacological characterization of the cat urotensin-II receptor (UT).
    Aiyar N; Johns DG; Ao Z; Disa J; Behm DJ; Foley JJ; Buckley PT; Sarau HM; van-der-Keyl HK; Elshourbagy NA; Douglas SA
    Biochem Pharmacol; 2005 Apr; 69(7):1069-79. PubMed ID: 15763543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1).
    Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA
    Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
    Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
    Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors.
    Qi JS; Minor LK; Smith C; Hu B; Yang J; Andrade-Gordon P; Damiano B
    Peptides; 2005 Apr; 26(4):683-90. PubMed ID: 15752584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new ligand for the urotensin II receptor.
    Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
    Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors.
    Herold CL; Behm DJ; Buckley PT; Foley JJ; Wixted WE; Sarau HM; Douglas SA
    Br J Pharmacol; 2003 May; 139(2):203-7. PubMed ID: 12770925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo.
    Behm DJ; Aiyar NV; Olzinski AR; McAtee JJ; Hilfiker MA; Dodson JW; Dowdell SE; Wang GZ; Goodman KB; Sehon CA; Harpel MR; Willette RN; Neeb MJ; Leach CA; Douglas SA
    Br J Pharmacol; 2010 Sep; 161(1):207-28. PubMed ID: 20718751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UII and UT in grouper: cloning and effects on the transcription of hormones related to growth control.
    Sun C; Duan D; Li B; Qin C; Jia J; Wang B; Dong H; Li W
    J Endocrinol; 2014 Jan; 220(1):35-48. PubMed ID: 24169050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor.
    Langmead CJ; Szekeres PG; Chambers JK; Ratcliffe SJ; Jones DN; Hirst WD; Price GW; Herdon HJ
    Br J Pharmacol; 2000 Oct; 131(4):683-8. PubMed ID: 11030716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay.
    Brkovic A; Hattenberger A; Kostenis E; Klabunde T; Flohr S; Kurz M; Bourgault S; Fournier A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1200-9. PubMed ID: 12807997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist.
    Behm DJ; Herold CL; Ohlstein EH; Knight SD; Dhanak D; Douglas SA
    Br J Pharmacol; 2002 Oct; 137(4):449-58. PubMed ID: 12359626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity.
    Song W; McDonald J; Camarda V; Calo G; Guerrini R; Marzola E; Thompson JP; Rowbotham DJ; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2006 May; 373(2):148-57. PubMed ID: 16596397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
    Walker MW; Miller RJ
    Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes.
    Diallo M; Jarry M; Desrues L; Castel H; Chatenet D; Leprince J; Vaudry H; Tonon MC; Gandolfo P
    Peptides; 2008 May; 29(5):813-9. PubMed ID: 18082287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.